Financial comparisons Vext Science, Inc.
Equities
VEXT
CA9255401064
Healthcare Facilities & Services
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2850 CAD | 0.00% |
|
+3.64% | +11.76% |
| 11-20 | Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 11-20 | Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025 |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 36M | - | -31.06% | - | - | 3.81x | |
| 186M | -9.55% | -5.9% | - | - | - | |
| 78.12M | 12.18% | 20.68% | - | - | - | |
| 562M | -15.13% | 0.84% | -79.18% | -9.34% | 1.9x | |
| 258M | -18.94% | 4.22% | - | - | 3.61x | |
| Average | 224M | -7.86% | -2.24% | -79.18% | -9.34% | 3.11x | |
| Weighted average by Cap. | 240M | -7.65% | 0.8% | -79.18% | -9.34% | 2.88x |
- Stock Market
- Equities
- VEXT Stock
- Sector Vext Science, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition